Author:
Godoy-Monzón D,Cid-Casteulani A,Svarzchtein S,Sasaki S,Pascual-Espinosa JM
Reference24 articles.
1. Leung TYM, Chan AYL, Chan EW, Chan VKY, Chui CSL, Cowling BJ, et al. Short- and potential long-term adverse health outcomes of COVID-19: a rapid review. Emerg Microbes Infect. 2020; 9(1): 2190-9. doi: 10.1080/22221751.2020.1825914.
2. Powell C, Chang C, Naguwa SM, Cheema G, Gershwin ME. Steroid induced osteonecrosis: An analysis of steroid dosing risk. Autoimmun Rev. 2010; 9(11): 721-43. doi: 10.1016/j.autrev.2010.06.007.
3. Jones JP. Osteonecrosis. In: Koopman WJ, ed. Arthritis and allied conditions: a textbook of rheumatology. 14th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2001. pp. 2143-64.
4. Callejas Rubio JL, Luna Del Castillo JD, de la Hera Fernández J, Guirao Arrabal E, Colmenero Ruiz M, Ortego Centeno N. Effectiveness of corticoid pulses in patients with cytokine storm syndrome induced by SARS-CoV-2 infection. Med Clin (Engl Ed). 2020; 155(4): 159-61.
5. RECOVERY Collaborative Group; Horby P, Lim WS, Emberson JR, Mafham M, Bell JL, et al. Dexamethasone in hospitalized patients with Covid-19. N Engl J Med. 2021; 384(8): 693-704.